OPKO Health’s Senior VP and BioReference CEO Jon R. Cohen retires; receives $1M severance

OPKO HEALTH, INC.

Dr. Jon R. Cohen retired as SVP of OPKO, Executive Chairman & CEO of BioReference, and board member effective Aug 16, 2022.
He will serve as advisor through Dec 31, 2022, then consultant through Aug 2023.
Severance includes $1,000,000 aggregate and full vesting acceleration of all unvested stock options as of Dec 31, 2022.
Retirement not due to any disagreement with the company on operations, policies, or practices.
Severance agreement includes confidentiality, non-solicitation, non-disparagement, and cooperation clauses.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jon R. Cohen

Senior Vice President and Executive Chairman and Chief Executive Officer

OPK · OPKO HEALTH, INC.

Effective: 2022-08-16
Filed: August 16, 2022, 7:59 PM ET

On August 16, 2022, Dr. Jon R. Cohen, retired from his positions as Senior Vice President of OPKO Health, Inc., a Delaware corporation (the “ Company ”), and Executive Chairman and Chief Executive Officer of BioReference Health, LLC

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jon R. Cohen retired as Senior Vice President and Executive Chairman and Chief Executive Officer at OPKO HEALTH, INC..

Action: retired
Role: Senior Vice President and Executive Chairman and Chief Executive Officer

Exact text from the filing

On August 16, 2022, Dr. Jon R. Cohen, retired from his positions as Senior Vice President of OPKO Health, Inc., a Delaware corporation (the “ Company ”), and Executive Chairman and Chief Executive Officer of BioReference Health, LLC

View on SEC.gov

OPKO HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0000944809-22-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.